BioSpace News Archive

Decibel Therapeutics will showcase capabilities across its inner ear-focused drug discovery and development platform at the 42nd annual mid-winter meeting of the Association for Research in Otolaryngology from February 9-13, 2019.

Palleon Pharmaceuticals announced that the company, together with the University of Dundee, has successfully defended an opposition to EP1954318

Latest wave of enhancements brings patients into the conversation and connects providers outside the four walls of the hospital, creating a fully connected healthcare community

Exicure, Inc. announced that its CEO, Dr. David Giljohann, will present a corporate update on Monday, February 11, 2019 at 11:15 am EST at the BIO CEO & Investor Conference.

Kleo Pharmaceuticals Inc. announced that its Chief Executive Officer Douglas J. Manion, M.D., FRCP(C), will present at the BIO CEO & Investor Conference to be held February 11-12, 2019, at the Marriott Marquis in New York’s Time Square.

Bravado Health, a premier health IT company, announced the expansion of its product portfolio to include the new Ayva patient education and engagement platform.

Clients’ technologies to shine brightly at largest health IT event of the year

OneFifteen, a new non-profit ecosystem dedicated to the full and sustained recovery of people living with opioid addiction, has been established in Dayton, Ohio, to deploy a tech-enabled system of care to treat substance abuse disorders, that includes a behavioral health treatment center, rehabilitation housing and wrap-around services.

Lifestyle Delivery Systems Inc. announces that its wholly-owned subsidiary, Core Isogenics Inc. has begun nursery operations at the Adelanto facility.

Thermo Fisher Scientific, the world leader in serving science, today announced that several of its analytical instruments have received multiple prestigious industry awards.